Agilent Technologies Inc. (A)
NYSE
Closed
Oct 6, 2026
Day's Range
168.0152 wk Range
108.35Overview - A - Agilent Technologies Inc.
Key Statistics
Valuation
Enterprise Value
49.69B
P/E (Trailing)
‪33.09‬
P/E (Forward)
‪24.82‬
PEG Ratio
‪3.90‬
Price / Sales (TTM)
‪6.41‬
Price / Book
‪6.42‬
EV / EBITDA
‪23.89‬
Profitability
Gross Margin
‪55.48%‬
Profit Margin
‪19.53%‬
Operating Margin
‪25.55%‬
Return on Assets
‪8.63%‬
Return on Equity
‪20.97%‬
Ownership
Shares Outstanding
281.96M
Float
280.96M
Short % of Shares Outstanding
‪2.04%‬
Held by Insiders
‪0.19%‬
Held by Institutions
‪95.40%‬
Price stats
Beta
‪1.24‬
50-Day Avg
‪152.53‬
200-Day Avg
‪132.83‬
Dividends
Payout Ratio
‪19.98%‬
Frequency
Quarterly
Analyst Consensus
22 analysts
Average price target
‪$ 160.85‬Shariah Compliance
Report Date: Feb 20, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - A - Agilent Technologies Inc.
Peers - A - Agilent Technologies Inc.
Peer Comparison
Compared with companies in Diagnostics & Research listed on NYSE.
- ANYSEAgilent Technologies Inc.47.30BMarket Cap+15.60%52-week change33.09P/E (Trailing)‪19.53%‬Profit Margin
- DHR.PR.ANYSEDanaher Corp1.29TMarket Cap—52-week change213.72P/E (Trailing)‪60.95%‬Profit Margin
- TMONYSEThermo Fisher Scientific Inc.242.11BMarket Cap+16.93%52-week change35.53P/E (Trailing)‪15.03%‬Profit Margin
- IQVNYSEIQVIA Holdings Inc.42.50BMarket Cap+20.60%52-week change32.16P/E (Trailing)‪8.09%‬Profit Margin
- WATNYSEWaters Corporation41.74BMarket Cap+22.95%52-week change107.38P/E (Trailing)‪3.58%‬Profit Margin
- DIDIANYSEState Street SPDR Dow Jones Industrial Average ETF Trust39.98BMarket Cap+8.66%52-week change20.75P/E (Trailing)—Profit Margin
- MTDNYSEMettler-Toledo International Inc.30.28BMarket Cap+21.19%52-week change34.11P/E (Trailing)‪21.90%‬Profit Margin
Profile Summary - A - Agilent Technologies Inc.
About
Agilent Technologies Inc. is a global life sciences, diagnostics, and applied markets company that provides instruments, software, consumables, and services for laboratory and analytical workflows. Its portfolio supports research, routine testing, and regulated environments across pharmaceuticals, clinical…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
